Efficacy, safety and biomarkers of SG001 for patients with previously treated recurrent or metastatic cervical cancer: an open-label, multicenter, phase Ib trial.
作者信息
Zuo Jing, Duan Wei, Zhao Mingxuan, Chen Zhendong, Lin Jie, Shi Huaqiu, Jiang Ou, Zhang Youzhong, Fang Meiyu, Wang Li, Wang Wei, Huang Yong, Yu Junyan, Zhang Xiaoxue, Pu Weiqing, Hao Deshun, She Fenglin, Yang Xiugao, Chen Ying, Tang Qizhi, Zhang Xiao, Niu Miao, Song Yan'e, Wu Lingying
机构信息
Department of Gynecology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P. R. China.
Department of Gynecology and Oncology, Beijing Obstetrics and Gynecology Hospital, Beijing, P. R. China.
出版信息
Cancer Commun (Lond). 2024 Sep;44(9):1042-1046. doi: 10.1002/cac2.12578. Epub 2024 Jul 23.
Abstract
摘要
Zotero 插件